Clinical Trial Update: PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

View source ↗

Summary

A proof-of-concept study is evaluating inhaled targeted imatinib nan formulations for pulmonary arterial hypertension and pulmonary fibrosis, and the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Fibrosis

Drugs mentioned

• Imatinib (Gleevec) (imatinib)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Pulmonary Arterial Hypertension (PAH), Lung Fibrosis Interstitial | Status: RECRUITING